• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BTL INDUSTRIES INC. EMSCULPT NEO; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BTL INDUSTRIES INC. EMSCULPT NEO; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Health Effect - Clinical Codes Hematoma (1884); Partial thickness (Second Degree) Burn (2694)
Date of Event 12/29/2021
Type of Reportable Event Serious Injury
Event or Problem Description
Emsculpt neo treatment device caused burn to skin (mid suprapubic with a 2 cm open erosion of the skin).The bottom portion of the device was resting on the area that was burned.The treatment also caused suspected abdominal hematoma - extreme tenderness to palpitation of lower right abdominal area muscle that took approximately 10 weeks to resolve.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMSCULPT NEO
Common Device Name
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
BTL INDUSTRIES INC.
MDR Report Key15210550
Report NumberMW5111429
Device Sequence Number6346812
Product Code GEI
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 08/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/10/2022
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
JOLESSA BIRTH CONTROL PILL; MULTIVITAMIN
Outcome Attributed to Adverse Event Other;
Patient Age52 YR
Patient SexFemale
Patient Weight57 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-